Therefore, the expression of RASGRF2-AS1, TBX2-AS1, NTF4, PTPRD-AS, ITGA11, and HID1-AS1 revealed the predicated potential for NSCLC patients. This evidence concerns the gene PTPRD and non-small cell lung carcinoma.